NEUROLOGY

Advancing the treatment in primary generalized tonic-clonic seizures: A novel time-to-event study of lacosamide

06 Sep 2021

Improving multiple sclerosis management in Hong Kong through integrative Western-Chinese medicine approach

16 Aug 2021

Interview with the Expert: Dr. Peter YM Woo - Glioblastoma Multiforme (GBM) Treatment with Combination of TTFields and Chemotherapy: When and Where to Implement TTFields in the Clinical Setting?

07 Jun 2021

Exploring the underlying causes and patient experience of myasthenia gravis

28 Jun 2021

Intracranial atherosclerotic disease: Stroke mechanisms, management and recurrence

30 Dec 2019

Local real-world study interim analysis demonstrates promising results: TTFields therapy on quality-of-life for newly diagnosed glioblastoma patients

30 Jun 2021
Expert Insight View All

Improving multiple sclerosis management in Hong Kong through integrative Western-Chinese medicine approach

Multiple sclerosis (MS) is among the most common central nervous system (CNS) inflammatory demyelinating diseases with an estimated global prevalence of 1 in 3,000 people in 2020.1 Although MS is regarded as relatively uncommon in the Asia Pacific Region and even rarer in Hong Kong with a local prev
16 Aug 2021
thumb

Dr. Alexander Yuk-lun LAU

Specialist in Neurology
Clinical Associate Professor (Honorary),
Department of Medicine and Therapeutics Medical Director,
Hong Kong Institute of Integrative Medicine,
The Chinese University of Hong Kong

Intracranial atherosclerotic disease: Stroke mechanisms, management and recurrence

Intracranial atherosclerosis (ICAS) is a major cause of ischemic stroke worldwide. Recurrent ischemic events are most commonly associated with ICAS than with other stroke subtypes.1
30 Dec 2019
thumb

Dr. Leung, Wai-Hong Thomas

Lee Quo Wei Professor of Neurology, Division of Neurology,
Department of Medicine and Therapeutics,
The Chinese University of Hong Kong
Conference update View All
thumb

AAN 2021

April 17-22, 2021 |

Virtual

Meeting Highlight View All

Local real-world study interim analysis demonstrates promising results: TTFields therapy on quality-of-life for newly diagnosed glioblastoma patients

NEUROLOGY
30 Jun 2021
thumb

Dr. Peter YM Woo

Specialist in Neurosurgery
Infographics

Strategy to prevent and control NCDs in Hong Kong by 2025
30 Aug 2019
News & perspective View All

Long-term neurologic symptoms emerge in 1 out of 3 patients hospitalized with COVID-19

With confirmed cases of the 2019 coronavirus disease (COVID-19) on the rise, neurological symptoms and syndromes have been reported by a significant proportion of patients in addition to the predominant respiratory symptoms.1-3 A recent study from Italy further demonstrated that long-term neurologic
28 Feb 2021

Olaparib lengthens the survival for men with metastatic castration-resistant prostate cancer compared to new hormone agents

Loss-of-function alterations in homologous recombination repair (HRR) genes are associated with more aggressive prostate cancer and sensitivity to poly (adenosine diphosphate–ribose) polymerase (PARP) inhibition treatment.1

31 Aug 2020
Features View All
NEUROLOGY

Advancing the treatment in primary generalized tonic-clonic seizures: A novel time-to-event study of lacosamide

06 Sep 2021